福瑞医科股价连续4天上涨累计涨幅12.72%，恒生前海基金旗下1只基金持4800股，浮盈赚取4.42万元

Group 1 - The core point of the article highlights the recent performance of Furuimei Medical, with a stock price increase of 12.72% over four consecutive days, reaching 81.50 CNY per share and a total market capitalization of 21.596 billion CNY [1] - Furuimei Medical, established on December 26, 2001, and listed on January 20, 2010, specializes in the production and sales of pharmaceuticals, instrument research and sales, and medical services, with revenue composition of 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Group 2 - The Hengsheng Qianhai High-end Manufacturing Mixed A Fund (013383) holds Furuimei Medical as its ninth largest position, with a current holding of 4,800 shares, representing 2.71% of the fund's net value [2] - The fund has seen a floating profit of approximately 12,480 CNY today, accumulating a total floating profit of 44,200 CNY during the four-day stock price increase [2] - The fund was established on June 29, 2022, with a current size of 9.0044 million CNY, and has achieved a year-to-date return of 4.82%, ranking 2,776 out of 9,012 in its category, and a one-year return of 85.8%, ranking 332 out of 8,157 [2]